CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 108 filers reported holding CHEMOCENTRYX INC in Q3 2018. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $82,000 | -97.2% | 6,122 | -91.6% | 0.00% | -100.0% |
| Q1 2020 | $2,938,000 | -66.5% | 73,128 | -67.0% | 0.02% | -57.5% |
| Q4 2019 | $8,767,000 | +124.9% | 221,677 | -61.4% | 0.04% | +135.3% |
| Q3 2019 | $3,899,000 | -49.1% | 574,970 | -30.1% | 0.02% | -54.1% |
| Q2 2019 | $7,656,000 | -28.9% | 823,080 | +6.2% | 0.04% | -19.6% |
| Q1 2019 | $10,765,000 | +20.5% | 775,123 | -5.3% | 0.05% | +4.5% |
| Q4 2018 | $8,931,000 | -21.2% | 818,489 | -8.7% | 0.04% | -6.4% |
| Q3 2018 | $11,330,000 | +15.7% | 896,380 | +20.6% | 0.05% | +11.9% |
| Q2 2018 | $9,789,000 | +37.9% | 743,298 | +42.4% | 0.04% | +35.5% |
| Q1 2018 | $7,099,000 | +171.8% | 521,864 | +18.9% | 0.03% | +181.8% |
| Q4 2017 | $2,612,000 | -29.2% | 438,838 | -11.7% | 0.01% | -31.2% |
| Q3 2017 | $3,689,000 | -55.5% | 497,195 | -43.8% | 0.02% | -57.9% |
| Q2 2017 | $8,287,000 | +33.3% | 885,442 | +3.7% | 0.04% | +35.7% |
| Q1 2017 | $6,216,000 | +86.4% | 853,718 | +89.4% | 0.03% | +75.0% |
| Q4 2016 | $3,334,000 | +220.6% | 450,809 | +161.6% | 0.02% | +220.0% |
| Q3 2016 | $1,040,000 | +4852.4% | 172,299 | +3511.4% | 0.01% | – |
| Q2 2016 | $21,000 | – | 4,771 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |